Winning Health Technology Group Co., Ltd. (300253.SZ)
- Previous Close
6.77 - Open
6.56 - Bid 6.93 x --
- Ask 6.94 x --
- Day's Range
6.73 - 6.95 - 52 Week Range
5.12 - 12.32 - Volume
27,448,639 - Avg. Volume
39,223,868 - Market Cap (intraday)
14.983B - Beta (5Y Monthly) 0.34
- PE Ratio (TTM)
43.38 - EPS (TTM)
0.16 - Earnings Date --
- Forward Dividend & Yield 0.01 (0.14%)
- Ex-Dividend Date Jun 15, 2023
- 1y Target Est
8.99
Winning Health Technology Group Co., Ltd. provides IT solutions for hospitals and medical service organizations in China. The company offers IT solution designing, planning and consulting, development, system building, maintenance, and operation services. Its solutions are used in building smart hospitals, regional healthcare regulation platforms, community healthcare regulation platforms, public health-care regulation platforms, medical insurance, and other health services. The company was formerly known as Shanghai Kingstar Winning Software Co., Ltd. and changed its name to Winning Health Technology Group Co., Ltd. in January 2016. The company was founded in 1994 and is based in Shanghai, China.
www.winning.com.cn6,258
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: 300253.SZ
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 300253.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 300253.SZ
Valuation Measures
Market Cap
14.98B
Enterprise Value
14.98B
Trailing P/E
42.55
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.81
Price/Book (mrq)
2.63
Enterprise Value/Revenue
4.74
Enterprise Value/EBITDA
25.91
Financial Highlights
Profitability and Income Statement
Profit Margin
11.32%
Return on Assets (ttm)
2.03%
Return on Equity (ttm)
5.88%
Revenue (ttm)
3.16B
Net Income Avi to Common (ttm)
357.96M
Diluted EPS (ttm)
0.16
Balance Sheet and Cash Flow
Total Cash (mrq)
1.11B
Total Debt/Equity (mrq)
19.33%
Levered Free Cash Flow (ttm)
-360.68M
Research Analysis: 300253.SZ
Company Insights: 300253.SZ
300253.SZ does not have Company Insights